European Research Area
Food, agriculture and fisheries, and biotechnology
Information and Communication Technologies (ICT)
Key Enabling Technologies
Marie Skłodowska-Curie Actions
New materials and new production technologies
SME - Small and Medium-sized Enterprises
Science with and for Society
Socio-Economic Sciences and Humanities
Systems Epigenetics: Towards Precision Cancer Medicine
27-30 November 2018, Amsterdam, Netherlands
This conference brings together scientists from multidisciplinary fields employing different research strategies:
- Epigenetic profiling at genome-wide and/or single cell level to identify complex dynamic regulatory interactions,
- Bioinformatics and mathematical modelling to understand and predict observed (dynamic) phenotypic responses,
- Innovative epigenetic interference tools using for instance CRISPR/dCas-based epigenetic editing tools to locally overwrite epigenetic signatures and to verify the impact of defined alterations in epigenetic regulation.
The meeting provides a platform for scientists focusing on fundamental and biomedical research, clinicians and private sector scientists.
The Systems Epigenetics: Towards Precision Cancer Medicine Conference is organized in the context of the EpiPredict EU H2020 Innovative Training Network (www.EpiPredict.eu) coordinated by Dr Pernette Verschure.
ICPerMed Conference 2018 'Personalised Medicine in Action'
20-21 November 2018, Berlin, Germany
The first ICPerMed Conference 'Personalised Medicine in Action' will take place on 20-21 November 2018 at the dbb forum in Berlin, Germany.
The main focus of this conference is to present best practice examples of successful implementation of personalised medicine approaches. This is complemented by high-level keynote talks addressing different aspects of personalised medicine.
The conference will start in the morning of November 20 at 9:00 AM and will finish on November 21 at 2:00 PM.
Parkinson's disease: causes and cures
8 November 2018, Brussels, Belgium
The workshop aims to provide a kaleidoscopic view of the latest research, treatments, and ways forward towards better understanding and being able to cure Parkinson's disease. The workshop aims to moreover look at how greater funding could enable such steps forward, both clinically and politically - especially in light of negotiations on the upcoming research framework programme, Horizon Europe. Finally, the session will also explore the possible links between toxins (herbicides and pesticides) with the disease.
Parkinson’s is a progressive neurodegenerative disorder having no known cause, typically with onset later in life. Prevalence in the 60-69-year-old population is estimated to be approximately 1.0%, rising to 2.7% in those over 80. There are more than one million people living with Parkinson’s today in Europe; with an ageing population this figure is forecast to double by 2030. The condition is characterised by difficulty in moving and tremor, as well as psychiatric issues. It leads to a progressive reduction in the quality of life and those affected require increasing care. This imposes a significant socioeconomic burden which currently amounts to €13.9 billion of healthcare expenditure annually.
This workshop is jointly organised by Member of the European Parliament Pavel Poc (S&D Group), the European Chemical Society (EuChemS), and the European Federation for Medicinal Chemistry (EFMC).
Roundtable event: "Building the roadmap to outcomes-based cancer care"
6 November 2018, Brussels, Belgium
This is a roundtable event to share the results of the ECCO-CODE joint research project on pragmatic outcome measurement and to chart a path forward for policy makers in respect to achieving the promise of outcomes based healthcare.
- Learn more about the immediate available steps to advance outcomes based payment models in cancer care
- Debate the next steps for governments, health systems, health professions and civic society to take to achieve a more sustainable future in which innovations in cancer care can flourish across Europe
- Influence the workplans of ECCO, CODE and others driving the debate on outcomes based cancer care
Representatives from the European Parliament, the European Commission, national governments, healthcare professions, academia, health NGOs, patient advocacy groups and ECCO member societies are all invited to attend and participate in this multi-stakeholder Roundtable.
European Health Challenges: The role of imaging technology in addressing key biomedical questions of the future
25 September 2018, Brussels, Belgium
The White Rose Universities of Leeds, Sheffield and York are home to some of the top European Centres in Advanced Imaging and Microscopy studying at a macromolecular level the impact of disease on individual cells, using a wealth of first class equipment to conduct world leading biological research.
Hear our panel of experts present their cutting edge research on the use of advanced imaging in the design of new medicines for the future. For the first time, imaging at near atomic level produces amazing pictures of cells actively dividing, incredible detail of organ damage eg to the lungs and investigation of how cells behave when attacked by a virus.